魏思乐说,情况在改善,尽管目前并不理想,却尚可容忍。
Conditions are improving, says Mr Vasella, and are now tolerable, if not ideal.
诺华制药美国发言人周一晚间说,无法联系到身处瑞士的魏思乐做出置评。
U. S. spokeswoman for Novartis said late Monday that Mr. Vasella couldn't be reached for comment in Switzerland.
魏思乐表示:“中国的医改意味着我们的业务将获得更多增长,而在其它国家,情况恰恰相反。”
"Healthcare reform in China means more growth in our operations, while in other countries it means less," said Mr Vasella.
应用推荐